Skip to main content

Table 2 Pregnancy outcome by exposure group

From: Safety of artemether-lumefantrine in pregnant women with malaria: results of a prospective cohort study in Zambia

Pregnancy outcome - n (%)

Artemether-lumefantrine

(N = 504)

Sulphadoxine-pyrimethamine

(N = 516)

Abortion (≤28 weeks of gestation)

7* (1.4)

8** (1.6)

Stillbirth (>28 weeks of gestation)

9 (1.8)

13 (2.5)

Preterm delivery (<37 completed weeks of gestation)

71 (14.1)

90 (17.4)

Full term delivery (≥37 completed weeks of gestation)

395 (78.4)

377 (73.1)

Unknown (mother withdrawn prior to delivery)

22 (4.4)

28 (5.4)

  1. Enrolled population: newborns, stillbirths, and aborted foetuses or pregnant women who were withdrawn prior to delivery.
  2. * All first trimester exposures.
  3. **5 abortions: one woman with triplets, one with twins - none had first trimester exposure.
  4. One patient from the AL group had an ectopic pregnancy with laparotomy performed to remove the foetus. This patient has pregnancy outcome "unknown" as she was withdrawn due to an adverse event (ectopic pregnancy) prior to "delivery".